Life-Threatening Cardiogenic Shock During Chemotherapy
Anthracycline-induced cardiotoxicity may be acute and unpredictable. In cardio-oncology patients with high bleeding risk, an Impella device may represent a safer and effective alternative to ECMO for circulatory support.
Authors
- Donato Antonio Paglianiti (ORCID: https://orcid.org/0000-0003-2556-4809)
- Marco Giuseppe Del Buono (ORCID: https://orcid.org/0000-0002-7483-6164)
- Gianluigi Saponara
- Carlo Trani
- Tommaso Sanna
- F Burzotta
- Alessia D'Aiello
- Daniela Pedicino
- Cristina Aurigemma
- Francesco Bianchini
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1016/j.jaccas.2026.107009
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 30.07